ArticleInternational journal of general medicine2025
Diagnostic Value of Homocysteine Metabolic Pathway in Coronary Atherosclerosis: A Study on Reference Intervals and Risk Prediction.
Article in International journal of general medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: To determine the reference intervals of homocysteine (Hcy) metabolic pathway in healthy adults using direct continuous sampling, and to explore their correlations with coronary atherosclerosis (CA) for improving the risk assessment and diagnostic accuracy of CA. Patients and Methods: A total of 426 reference individuals were selected via direct continuous sampling of the two centers from healthy adults based on questionnaires and laboratory indicators. Additionally, 75 patients were diagnosed with CA by cardiologists. Standardized analysis of Hcy, cysteine (Cys) and methionine (Met) levels in serum were conducted using commercial assay kits compatible with LC-MS/MS. Results: Although Met and Hcy showed significant differences between the sexes, they could not meet the criteria for setting reference intervals. After outlier removal and normality conversion, 95% reference intervals of Hcy, Cys and Met were calculated as 7-25 μmol/L, 227-410 μmol/L, and 21-39 μmol/L, respectively. In addition, the correlations among Hcy, Cys, and Met were influenced by CA, and each served as an independent risk factor. The area under the curve (AUC) for the combined three indicators increased to 0.86 (95% CI: 0.81-0.91). The specificity increased to 83%, while the sensitivity reached 78%. Conclusion: The Hcy metabolic pathway significantly enhances risk assessment capability and may be helpful in providing reference values for the diagnosis and risk prediction of CA.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.